Medindia
Medindia LOGIN REGISTER
Advertisement

GC Pharma Reports Q2 2019 Results

Tuesday, July 30, 2019 General News
Advertisement
Profitability has improved Through International expansion

Key Figures

Q2 2019(1)

Growth(1)

Total revenues

KRW 359.6 billion

+5.2%

Operating profit

KRW 19.6 billion

+47.5%

K-IFRS profit after taxation

KRW -15 billion

NA

(1) Results and percentages compare to equivalent 2018 period.

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close